#
Progress Update: A cell culture model of innate immunity for FSHD
Jul 31, 2018
Charles Emerson provides the final update on his recent study.
#
Progress Update: Defining the role of post-translational modification on FSHD protein DUX4
Jul 17, 2018
Jocelyn Eidahl, Post-Doctoral Scientist at Nationwide Children’s Hospital provides a progress update.
#
FSHD Research Funding Overview 2017
Jul 11, 2018
Reporting on worldwide funding of FSHD research.
#
Progress Update: 3rd Gen Oligonucleotide Targeting DUX4 in Mouse Model
Jul 11, 2018
Yi-Wen Chen DMV PhD provides an update on investigating 3rd generation oligonucleotides.
#
Muscle Stem Cells from Teratomas
Jul 10, 2018
Michael Kyba's lab shows that functional skeletal muscle stem cells can be produced from mouse pluripotent stem cells without genetic modification through teratoma formation. As few as 40,000 teratoma-derived cells can regenerate 80% of total muscle volume, improve force generation, and mature into functional muscle stem cells in vivo.
#
Progress Update: Optimizing the Utility of the National Registry for FSHD Research and Trial Recruitment
Jul 5, 2018
Dr. Tawil provides an update on year two of his project to get genetic testing performed for those in the registry who do not have it, and thus create a larger viable pool for upcoming therapeutic trials.